<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_PcpNtrU">Cost-effectiveness of a mobile-phone text messaging intervention on type 2 diabetes-A randomized-controlled trial</title>
				<funder>
					<orgName type="full">BMZ</orgName>
				</funder>
				<funder ref="#_w8ax4A8">
					<orgName type="full">Ludwig-Maximilians-Universitat, Munich, Germany</orgName>
				</funder>
				<funder>
					<orgName type="full">Institute for Physical Activity and Nutrition</orgName>
					<orgName type="abbreviated">IPAN</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100015144</idno>
				</funder>
				<funder>
					<orgName type="full">Deakin University</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100001778</idno>
				</funder>
				<funder>
					<orgName type="full">DAAD</orgName>
				</funder>
				<funder>
					<orgName type="full">EXCEED</orgName>
				</funder>
				<funder>
					<orgName type="full">High Blood Pressure Research Council of Australia</orgName>
					<orgName type="abbreviated">HBPRCA</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100001201</idno>
				</funder>
				<funder>
					<orgName type="full">Center for International Health</orgName>
					<orgName type="abbreviated">CIH</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100009055</idno>
				</funder>
				<funder>
					<orgName type="full">ICDDR</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">© 2019 Published by Elsevier Ltd on behalf of Fellowship of Postgraduate Medicine. © 2019 Published by Elsevier Ltd on behalf of Fellowship of Postgraduate Medicine.</p>
				</availability>
				<date type="published" when="2019-12-16">16 December 2019</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Sheikh</roleName><forename type="first">Mohammed</forename><forename type="middle">Shariful</forename><surname>Islam</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Institute for Physical Activity and Nutrition (IPAN) , School of Exercise and Nutrition Sciences , Faculty of Health , Deakin University , 221 Burwood Highway , Burwood , Melbourne , VIC 3125 , Australia</note>
								<orgName type="department" key="dep1">Institute for Physical Activity and Nutrition (IPAN)</orgName>
								<orgName type="department" key="dep2">School of Exercise and Nutrition Sciences</orgName>
								<orgName type="department" key="dep3">Faculty of Health</orgName>
								<orgName type="institution">Deakin University</orgName>
								<address>
									<addrLine>221 Burwood Highway</addrLine>
									<postCode>3125</postCode>
									<settlement>Burwood Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> The George Institute for Global Health , University of New South Wales , 83-117 Missenden Road , Camperdown , Sydney , NSW 2050 , Australia</note>
								<orgName type="department">The George Institute for Global Health</orgName>
								<orgName type="institution">University of New South Wales</orgName>
								<address>
									<addrLine>83-117 Missenden Road</addrLine>
									<postCode>2050</postCode>
									<settlement>Camperdown Sydney</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>c</label> Sydney Medical School , The University of Sydney , Camperdown , Sydney , NSW 2050 , Australia</note>
								<orgName type="department">Sydney Medical School</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<postCode>2050</postCode>
									<settlement>Camperdown Sydney</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ralph</forename><surname>Peiffer</surname></persName>
							<email>ralph.peiffer@helmholtz-muenchen.de</email>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>d</label> Biometry and Epidemiology , Institute for Medical Informatics , Ludwig-Maximilians-University Munich , Marchioninistr. 15 , Munich 81377 , Germany</note>
								<orgName type="department" key="dep1">Biometry and Epidemiology</orgName>
								<orgName type="department" key="dep2">Institute for Medical Informatics</orgName>
								<orgName type="institution">Ludwig-Maximilians-University Munich</orgName>
								<address>
									<addrLine>Marchioninistr. 15</addrLine>
									<postCode>81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>e</label> Institute of Health Economics and Health Care Management , Helmholtz Zentrum M ϋnchen (Gmbh) , German Research Center for Environmental Health , Ingolstädter Landstr. 1 , Neuherberg/ Munich 85764 , Germany</note>
								<orgName type="department" key="dep1">Institute of Health Economics and Health Care Management</orgName>
								<orgName type="department" key="dep2">German Research Center for Environmental Health</orgName>
								<orgName type="institution">Helmholtz Zentrum M ϋnchen (Gmbh)</orgName>
								<address>
									<addrLine>Ingolstädter Landstr. 1 Neuherberg/</addrLine>
									<postCode>85764</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Clara</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
							<email>clara.chow@sydney.edu.au</email>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> The George Institute for Global Health , University of New South Wales , 83-117 Missenden Road , Camperdown , Sydney , NSW 2050 , Australia</note>
								<orgName type="department">The George Institute for Global Health</orgName>
								<orgName type="institution">University of New South Wales</orgName>
								<address>
									<addrLine>83-117 Missenden Road</addrLine>
									<postCode>2050</postCode>
									<settlement>Camperdown Sydney</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ralph</forename><surname>Maddison</surname></persName>
							<email>ralph.maddison@deakin.edu.au</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Institute for Physical Activity and Nutrition (IPAN) , School of Exercise and Nutrition Sciences , Faculty of Health , Deakin University , 221 Burwood Highway , Burwood , Melbourne , VIC 3125 , Australia</note>
								<orgName type="department" key="dep1">Institute for Physical Activity and Nutrition (IPAN)</orgName>
								<orgName type="department" key="dep2">School of Exercise and Nutrition Sciences</orgName>
								<orgName type="department" key="dep3">Faculty of Health</orgName>
								<orgName type="institution">Deakin University</orgName>
								<address>
									<addrLine>221 Burwood Highway</addrLine>
									<postCode>3125</postCode>
									<settlement>Burwood Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Lechner</surname></persName>
							<email>andreas.lechner@med.uni-muenchen.de</email>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>e</label> Institute of Health Economics and Health Care Management , Helmholtz Zentrum M ϋnchen (Gmbh) , German Research Center for Environmental Health , Ingolstädter Landstr. 1 , Neuherberg/ Munich 85764 , Germany</note>
								<orgName type="department" key="dep1">Institute of Health Economics and Health Care Management</orgName>
								<orgName type="department" key="dep2">German Research Center for Environmental Health</orgName>
								<orgName type="institution">Helmholtz Zentrum M ϋnchen (Gmbh)</orgName>
								<address>
									<addrLine>Ingolstädter Landstr. 1 Neuherberg/</addrLine>
									<postCode>85764</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>f</label> German Center for Diabetes Research (DZD) , Ingolstädter Landstr. 1 , Neuherberg/ Munich 85764 , Germany</note>
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<addrLine>Ingolstädter Landstr. 1 Neuherberg/</addrLine>
									<postCode>85764</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rolf</forename><surname>Holle</surname></persName>
							<email>holle@helmholtz-muenchen.de</email>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>d</label> Biometry and Epidemiology , Institute for Medical Informatics , Ludwig-Maximilians-University Munich , Marchioninistr. 15 , Munich 81377 , Germany</note>
								<orgName type="department" key="dep1">Biometry and Epidemiology</orgName>
								<orgName type="department" key="dep2">Institute for Medical Informatics</orgName>
								<orgName type="institution">Ludwig-Maximilians-University Munich</orgName>
								<address>
									<addrLine>Marchioninistr. 15</addrLine>
									<postCode>81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>e</label> Institute of Health Economics and Health Care Management , Helmholtz Zentrum M ϋnchen (Gmbh) , German Research Center for Environmental Health , Ingolstädter Landstr. 1 , Neuherberg/ Munich 85764 , Germany</note>
								<orgName type="department" key="dep1">Institute of Health Economics and Health Care Management</orgName>
								<orgName type="department" key="dep2">German Research Center for Environmental Health</orgName>
								<orgName type="institution">Helmholtz Zentrum M ϋnchen (Gmbh)</orgName>
								<address>
									<addrLine>Ingolstädter Landstr. 1 Neuherberg/</addrLine>
									<postCode>85764</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>f</label> German Center for Diabetes Research (DZD) , Ingolstädter Landstr. 1 , Neuherberg/ Munich 85764 , Germany</note>
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<addrLine>Ingolstädter Landstr. 1 Neuherberg/</addrLine>
									<postCode>85764</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Louis</forename><surname>Niessen</surname></persName>
							<email>louis.niessen@lstmed.ac.uk</email>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>g</label> Health Economics Unit , Centre for Applied Health Research and Delivery , Liverpool School of Tropical Medicine , Liverpool L1 6DQ , UK</note>
								<orgName type="department" key="dep1">Health Economics Unit</orgName>
								<orgName type="department" key="dep2">Centre for Applied Health Research and Delivery</orgName>
								<orgName type="institution">Liverpool School of Tropical Medicine</orgName>
								<address>
									<postCode>L1 6DQ</postCode>
									<settlement>Liverpool</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<note type="raw_affiliation"><label>h</label> Johns Hopkins School of Public Health , Baltimore , MD , USA</note>
								<orgName type="institution">Johns Hopkins School of Public Health</orgName>
								<address>
									<settlement>Baltimore</settlement>
									<region>MD</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Laxy</surname></persName>
							<email>michael.laxy@helmholtz-muenchen.de</email>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>e</label> Institute of Health Economics and Health Care Management , Helmholtz Zentrum M ϋnchen (Gmbh) , German Research Center for Environmental Health , Ingolstädter Landstr. 1 , Neuherberg/ Munich 85764 , Germany</note>
								<orgName type="department" key="dep1">Institute of Health Economics and Health Care Management</orgName>
								<orgName type="department" key="dep2">German Research Center for Environmental Health</orgName>
								<orgName type="institution">Helmholtz Zentrum M ϋnchen (Gmbh)</orgName>
								<address>
									<addrLine>Ingolstädter Landstr. 1 Neuherberg/</addrLine>
									<postCode>85764</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>f</label> German Center for Diabetes Research (DZD) , Ingolstädter Landstr. 1 , Neuherberg/ Munich 85764 , Germany</note>
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<addrLine>Ingolstädter Landstr. 1 Neuherberg/</addrLine>
									<postCode>85764</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_TaWGVVp">Cost-effectiveness of a mobile-phone text messaging intervention on type 2 diabetes-A randomized-controlled trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2019-12-16">16 December 2019</date>
						</imprint>
					</monogr>
					<idno type="MD5">AC7F6759B076FBACDCB4EDC512C7269B</idno>
					<idno type="DOI">10.1016/j.hlpt.2019.12.003</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T12:46+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords xml:id="_3ZDuxqu">mHealth Chronic diseases Health systems Willingness-to-pay Quality</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_YZbNwWB"><p xml:id="_H8fDKBS"><s xml:id="_emjbw4D">adjusted life years Economic evaluation Low-and middle-income countries</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.245" lry="793.92"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.245" lry="793.92"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.245" lry="793.92"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.245" lry="793.92"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.245" lry="793.92"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.245" lry="793.92"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.245" lry="793.92"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HaeEnzB">Introduction</head><p xml:id="_CDxM5p3"><s xml:id="_FXgQEmj">The prevalence of type 2 diabetes mellitus in low-and-middleincome countries (LMICs) is rising, and the long-term complica-tions entail a substantial burden of disease and financial costs <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref> .</s><s xml:id="_vMd4PA5">In Bangladesh, the prevalence of type 2 diabetes is increasing in both urban and rural areas, and the number of adults diagnosed with type 2 diabetes is estimated to double from 7.1 million in 2015 to 13.6 million in 2040 <ref type="bibr">[ 4 , 5 ]</ref>.</s><s xml:id="_9ZQBJ9Y">The majority of patients with type 2 diabetes in Bangladesh have uncontrolled diabetes with a high prevalence of risk factors that might contribute to early development of complications <ref type="bibr" target="#b5">[6]</ref> .</s></p><p xml:id="_anAZzZk"><s xml:id="_ArGqmnA">Diabetes imposes a severe impact on physical and mental health and quality of life in the Bangladeshi population <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref> .</s><s xml:id="_tTXUNt3">A large case-control study in an urban area of Bangladesh comparing 591 type 2 diabetes adults with 591 age, sex and residence matched controls reported that patients with type 2 diabetes reported almost twice the rates of depression and that depression was significantly associated with diabetes independent of sociodemographic and comorbidity <ref type="bibr" target="#b9">[10]</ref> .</s><s xml:id="_W9yV8SH">This case-control study showed that patients with type 2 diabetes in Bangladesh paid on average six times more for healthcare services than non-diabetics <ref type="bibr" target="#b10">[11]</ref> .</s><s xml:id="_h3M8CnJ">According to the Asian Development Bank, almost one-fourth (24.3%) of the Bangladeshi population live below the poverty line in 2019 <ref type="bibr" target="#b11">[12]</ref> .</s><s xml:id="_Hwbqh8c">Hence, it is crucial to develop effective and cost-effective interventions in the management of diabetes.</s></p><p xml:id="_eJQgyhS"><s xml:id="_DkNkvCU">Mobile phone use has increased globally, especially in LMICs.</s><s xml:id="_G7nG85t">In Bangladesh, the number of mobile phone subscribers increased from 86.5 million in 2012 to 163.4 million in 2019 and reached all segments of the population <ref type="bibr">[ 13 , 14 ]</ref>.</s><s xml:id="_BHP8pvw">Evidence suggests that mobile phone health (mHealth) interventions might be an effective, relatively low-cost approach in the treatment of chronic diseases such as diabetes, coronary heart diseases, depression, smoking, hypertension among others <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref> .</s><s xml:id="_aQtXQBs">Previously, we demonstrated in a randomized controlled trial that a text messaging intervention was effective at substantially reducing glycemia in type 2 diabetes patients in Bangladesh <ref type="bibr" target="#b24">[25]</ref> .</s><s xml:id="_fZkP89S">Given the limited financial resources available and the rapid rise in the number of mobile phones, mHealth is a promising tool to alleviate the burden of diabetes and financial costs for patients, the health system, and society <ref type="bibr" target="#b25">[26]</ref> .</s><s xml:id="_mTCmbZe">Mobile phone text messaging programs have been shown to be cost effective in smoking cessation <ref type="bibr">[ 27 , 28 ]</ref>{Patel, 2017 #164} <ref type="bibr" target="#b60">[61]</ref> .</s><s xml:id="_NptzAJN">A recent telehealth program in the UK for patients with depression showed an incremental quality-adjusted life years (QALY) gain of 0.001 (95% CI -0.023 to 0.026) with net monetary benefit at a cost-effectiveness threshold of £20 0 0 0 at 12 months <ref type="bibr" target="#b28">[29]</ref> .</s><s xml:id="_z9aKjtQ">A pilot telehealth program in patients with chronic obstructive pulmonary disease reported average saving of £1023 ($1280) per patient per year <ref type="bibr" target="#b29">[30]</ref> .</s><s xml:id="_MXwHBuN">Another telehealth program for patients with increased cardiovascular disease risk showed an incremental QALY gain of 0.012 (95% CI -0.001 to 0.026) with net monetary benefit at a cost-effectiveness threshold of £20 0 0 0 per QALY (95% CI -58 to 291) <ref type="bibr" target="#b30">[31]</ref> .</s><s xml:id="_KjaYtQ2">The TEXT ME study showed that for a target population of 50 0 0 0 patients with coronary heart disease, the intervention is expected to lead to 563 fewer myocardial infarctions, 361 fewer strokes and 1143 additional QALYs with an overall saving of $10.56 million for the health system over the patients' lifetimes <ref type="bibr" target="#b31">[32]</ref> .</s><s xml:id="_FK29jWm">The few mHealth cost-effectiveness studies in people with diabetes are from high-income countries, and evidence from LMICs is scarce <ref type="bibr">[ 26 , 33 ]</ref>.</s><s xml:id="_Xf5SvdK">In this study, we aimed to assess the cost-effectiveness of a text messaging intervention in patients with type 2 diabetes in Bangladesh.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AyE3e3T">Subjects</head><p xml:id="_grq3ePv"><s xml:id="_wJKqjbb">This was a 6-month, prospective, parallel-group, individual, randomized, controlled, single-center clinical trial designed to evaluate the effectiveness and cost-effectiveness of mobile phone text messaging in addition to standard care compared with standard care alone for glycemic control in patients with type 2 diabetes.</s><s xml:id="_yvFucs2">The study protocol has been published <ref type="bibr" target="#b13">[14]</ref> .</s><s xml:id="_GhHUapD">In short, participants were adults diagnosed with type 2 diabetes within the last 5 years attending the outpatient department of the Bangladesh Institute of Health Science (BIHS) hospital between September 2013 and August 2014, on oral medication with access to mobile phones, and able to read text messages.</s><s xml:id="_yjpfnpk">The diabetes status of participants was confirmed by a BIHS attending physician as per World Health Organization guidelines <ref type="bibr" target="#b13">[14]</ref> .</s><s xml:id="_mMs4hWu">All patients provided written informed consent at enrollment.</s><s xml:id="_q2yxj6w">The study protocol (PR#13,068) was approved by the Research Review Committee and Ethical Review Committee of the International Center for Diarrhoeal Diseases Research, Bangladesh (ICDDR,B) and received an Ethical Commit-tee waiver from Ludwig-Maximilians-Universität (LMU) and BIHS.</s><s xml:id="_TznZBnV">The study was conducted in accordance with the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Guideline for Good Clinical Practice and the Declaration of Helsinki 2008.</s><s xml:id="_rKrwp7S">This trial was registered with the German Clinical Trial Registry (drks.de),</s><s xml:id="_dD65CYY">DRKS0 0 0 05188.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yGaPEuc">Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NzEXtFZ">Randomization and masking</head><p xml:id="_XkgSghe"><s xml:id="_n8nZkGj">Patients were randomly assigned (1:1) to the text messaging intervention plus standard care or standard care alone.</s><s xml:id="_RjrsukG">The principal investigator generated the randomization numbers using a random number-generating program (GraphPad Software, Inc., La Jolla, CA, USA) and participants were assigned directly from the computer.</s><s xml:id="_9Cj7b6D">Laboratory personnel and all investigators were blinded to the participants' group allocation until the end of the observation period.</s><s xml:id="_rEtFdHW">Clinic staff and participants could not be masked because the intervention required active overt participation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_kG5wJCX">Data collection</head><p xml:id="_CkHQycg"><s xml:id="_9Y8A6fr">Data were collected through face-to-face interviews, using a structured questionnaire, physical examinations, and blood tests at baseline and follow-up.</s><s xml:id="_GeFb9Na">The interview and questionnaires contained questions about socio-demographics (age, sex, religion, education, marital status, occupation, income, family size, family income, objects owned), self-management behavior (tobacco use, medication adherence, physical activity and diet), health seeking behavior (type of doctor visited during the past year, number of visits, distance travelled for consultation and expenditure for health), medication use, healthcare use and costs among others.</s><s xml:id="_Pakn8Sz">Examinations included blood pressure measurements, anthropometric measurements, and laboratory measurements of blood samples that were analyzed at the BIHS biochemistry and research laboratories <ref type="bibr" target="#b13">[14]</ref> .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_R8nFC8S">Sample size calculation</head><p xml:id="_77t2Y86"><s xml:id="_xvdjwbz">We based the sample size calculation on the hypothesis that the mobile phone SMS intervention is superior to standard care in reducing glycated haemoglobin (HbA1c) by 0.5 points <ref type="bibr" target="#b33">[34]</ref> .</s><s xml:id="_tYvaAqr">Assuming a standard deviation of 1 and an alpha error level of 5%, the two-tailed calculation provided a power of over 90% with 90 participants in each arm of the study.</s><s xml:id="_fFMuFy4">To allow for a 20% dropout rate, a total of 226 participants were required for the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xN9mnBA">Intervention</head><p xml:id="_5TvM9d5"><s xml:id="_QAc3bMe">The text messages were developed and formulated through a consensus team including general medical practitioners, endocrinologists, cardiologists, epidemiologists, nurses, and medical students, based on national and international guidelines <ref type="bibr">[ 35 , 36 ]</ref>.</s><s xml:id="_uRjXzAu">Some 105 text messages were sent to 50 random individuals with diabetes in the pre-test stage using snowball sampling.</s><s xml:id="_rcha58P">Feedback from the participants led to adaptation of the contents of text messages, and 90 messages were finally selected.</s><s xml:id="_FfXvrFq">The text messages were developed based on the principles of Behavioral Learning Theory and the Transtheoretical Model of behavioral change <ref type="bibr">[ 37 , 38 ]</ref>.</s><s xml:id="_dCBhx9S">Participants in the intervention group received the 90 text messages randomly, once a day over a 6-month period, i.e., each patient received a text message twice over the follow-up period.</s></p><p xml:id="_prG8TbZ"><s xml:id="_XGPPsuv">Examples of text messages: 'A healthy diet will keep you healthy and happy'; 'If you are stressed, stop your work.</s><s xml:id="_tu5nunV">Go for a walk and relax!'; 'Taking medication timely will help to keep your blood sugar in control and avoid complications'.</s><s xml:id="_t4nhSjh">A text messages delivery website was created, and messages were delivered with technical support from a commercial telecom operator Grameenphone Bangladesh.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_wQxNtBp">Within trial economic evaluation</head><p xml:id="_Y6uqXHQ"><s xml:id="_wu7QuuY">The economic evaluation used a within-trial cost-effectiveness approach over the 6-month trial period conducted from a health service system perspective using generalized cost-effectiveness analysis (CEA) as adopted by the WHO cost effectiveness and strategic planning (WHO -CHOICE) guideline <ref type="bibr">[ 39 , 40 ]</ref>, which is widely accepted and comparable for identification of current allocative inefficiencies as well as opportunities presented by new interventions such as a text messaging program <ref type="bibr">[ 39 , 40 ]</ref>.</s><s xml:id="_hZu2T38">Given the short follow-up, no discounting was applied.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_M9EqsU8">Incremental health effects</head><p xml:id="_Csz4XKU"><s xml:id="_QdcQZ4a">The reduction in glycated haemoglobin (HbA1c) as well as improvements in quality-adjusted life over the 6-month follow-up period were chosen as measures of effect.</s><s xml:id="_e7zZb9N">This choice was informed by previous economic evaluations of mHealth or eHealth interventions on glycemic control reporting percentage reductions in HbA1c and QALYs as effect measures <ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref> .</s></p><p xml:id="_jUsx3RS"><s xml:id="_3VhfDaa">HbA1c reduction: The effect of the intervention on the primary endpoint (HbA1c) was reported previously <ref type="bibr" target="#b24">[25]</ref> .</s><s xml:id="_K6RZkQd">We revisited this analysis using a multivariate linear regression model, adjusted for age, sex, and baseline values, following intention to treat principles to quantify HbA1c as an effect measure.</s><s xml:id="_V8DQZgT">In order to approximate the potential long-term effects of the observed HbA1c change, we used the UK Prospective Diabetes Study (UKPDS) risk engine to calculate and compare the absolute 10-year risk of fatal or non-fatal coronary heart disease (CHD) and stroke in the routine care and intervention group (UKPDS Risk Engine, Oxford University Innovation Ltd, 2001).</s><s xml:id="_ktnUYA7">The risk engine is based on a series of risk factors and demographic information.</s><s xml:id="_daWJxKC">We ran the model developed for Asians, with mean characteristics of the entire study population once with the adjusted HbA1c mean of the intervention group and once with the HbA1c mean of the control group.</s></p><p xml:id="_wbn8CYR"><s xml:id="_ea8knGY">Quality-adjusted life years (QALYs): Health-related quality of life was assessed using the EuroQol five-dimensional questionnaire (EQ-5D-3L) <ref type="bibr" target="#b43">[44]</ref> .</s><s xml:id="_NGuc2w2">The EQ-5D-3L is a multi-attribute descriptive system comprising five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each of which has three response levels (no problems/some or moderate problems/extreme problems).</s><s xml:id="_R6NjeSP">The 243 resulting health states can be converted into a single preference score, the EQ-5D index score, based on time trade-off valuations derived from valuations of the general population.</s><s xml:id="_XyqFA8S">As a value tariff based on the preferences of the Bangladeshi population is lacking, preference scores were calculated using the value tariff for the UK <ref type="bibr" target="#b44">[45]</ref> .</s></p><p xml:id="_Y6wBfbU"><s xml:id="_PjgqKEx">Accumulated QALYs, a commonly used measure in economic evaluations that combines the quality of life and length of life <ref type="bibr" target="#b45">[46]</ref> , were derived over the 6-month intervention period for both groups by estimating the area under the utility curve assuming a constant change from baseline to follow-up.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9jdR7Tz">Incremental costs</head><p xml:id="_X2Szspu"><s xml:id="_GCqVNVp">Incremental costs for interventions were categorized into program costs and intervention costs <ref type="bibr" target="#b39">[40]</ref> .</s><s xml:id="_6e7pVZJ">Program costs include expenses for developing study content, study start-up and support for ongoing implementation, whereas intervention costs refer to recurrent costs resulting from the delivery of the intervention content and incremental healthcare costs resulting from differences in the utilization of health care resources.</s><s xml:id="_SZ5TEJN">As expenses for developing the intervention are marginal as soon as it is launched to a larger population, these were not considered in our calculation.</s><s xml:id="_P8QmeGX">Patient costs for maintaining the intervention were derived from internal accounting and included unit salary costs multiplied by intervention-allocated time of the research staff involved.</s><s xml:id="_MryUAWA">Patient costs for the SMS service were derived from invoices from the mobile operator.</s><s xml:id="_tJTqfB9">Information on healthcare utilization was unavailable at follow-up, so these costs were not incorporated in our evaluation.</s></p><p xml:id="_vkJ4P6s"><s xml:id="_8TWpKtm">Estimated total incremental costs for the intervention were divided by the number of participants randomized to the intervention group to obtain incremental per capita costs.</s><s xml:id="_CsfveUk">Discounting rates were not applied.</s><s xml:id="_abUnDsK">All costs incurred in Bangladesh Taka (BDT) were converted to US dollars (US$), using the conversion rate of December 31, 2013 (study period) in a first step <ref type="bibr" target="#b46">[47]</ref> .</s><s xml:id="_EvFW2Gc">Then, US$ were converted to international dollars (Intl.$) adjusting for the estimated purchasing power parity (PPP) conversion factor specific for Bangladesh <ref type="bibr" target="#b47">[48]</ref> .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8ntm3yQ">Incremental cost-effectiveness ratio</head><p xml:id="_WJPV9yk"><s xml:id="_MjxFqSw">The adjusted differences in HbA1c and in accumulated QALYs at 6-month follow-up were set in relation to incremental costs of the intervention.</s><s xml:id="_CpSMbtk">Incremental cost-effectiveness ratios (ICERs) were estimated as cost per 1%-unit reduction in HbA1c and per gain in accumulated QALYs.</s><s xml:id="_SwcHNcX">As incremental costs were estimated based on internal accounting, no uncertainty measure was assessed for the ICERs.</s><s xml:id="_TqwQXAm">All analyses were conducted using SAS 9.3 (Cary, NC, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QF54YAA">Sensitivity analyses</head><p xml:id="_kKvKeut"><s xml:id="_JusUZDu">As the estimations for the program costs were crude approximations based on the expert opinions of the study team and on internal accounting, we varied those estimations by a factor of 2 in both directions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_t6gJKUb">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yASqxVg">Descriptive statistics</head><p xml:id="_Z94Aser"><s xml:id="_4P7hwFq">Two hundred and thirty-six participants were randomized to either the intervention (n = 118) or the control group ( n = 118).</s><s xml:id="_frarwRy">Loss to follow-up was 15%, with 106 participants in the intervention group and 94 in the control group returning for follow-up ( Fig. <ref type="figure" target="#fig_0">1</ref> ).</s><s xml:id="_47dvtGb">The trial was completed as per protocol after 6 months.</s><s xml:id="_AQZF4py">The baseline demographics and characteristics of the study population are summarized in Table <ref type="table" target="#tab_0">1</ref> .</s><s xml:id="_VjySTSN">Mean age was 48 (9.6) years, and 45% of the participants were male.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jdfM5Xu">Incremental costs, effects, and incremental cost-effectiveness ratios</head><p xml:id="_rPWcM7A"><s xml:id="_jt52mas">Total program costs were 1811 Intl.$, and costs for sending text messages were 1031 Intl.$.</s><s xml:id="_9g75BYM">The total costs of the intervention were 2842 Intl.$, and mean intervention costs per participant were 24 Intl.$.</s></p><p xml:id="_tcXuqug"><s xml:id="_5qRyg76">As reported previously a statistically significant difference in HbA1c was observed in favor of the intervention group <ref type="bibr" target="#b24">[25]</ref> .</s><s xml:id="_mxf2Qcm">The sex-and age-adjusted difference in HbA1c between the intervention and the control group averaged -0.64% (95% CI: -0.95; -0.33).</s><s xml:id="_5DeXZW6">Using the UKPDS risk engine it was estimated that an HbA1c reduction of 0.64% in this sample would approximately yield an absolute 10-year CHD and stroke risk reduction of 0.5% and 0.0% respectively.</s></p><p xml:id="_WARAenv"><s xml:id="_a3PtYAv">The adjusted difference in the EQ-5D index at follow-up was 0.04 units (95% CI: 0.00; 0.08), translating to a difference of 0.010 (95% CI: 0.0 0 0; 0.021) QALYs, i.e., about 3.65 quality-adjusted days   (not statistically significant) over the 6-month period.</s><s xml:id="_NYQzj67">This results in ICERs of 38 Int.$ per 1% reduction in HbA1c and of 2406 Intl.$ per QALY gained ( Table <ref type="table" target="#tab_1">2</ref> ).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8rBquuV">Observations on sensitive analysis</head><p xml:id="_gQHV8XK"><s xml:id="_xHDG2tw">If the program costs were halved, the average gain in ICER would be 18 Int.$/1%</s><s xml:id="_EHfSHe3">HbA1c reduction and 1203 Int$/QALY gained.</s><s xml:id="_nsku9hx">Similarly, if the program costs were doubled, the average gain in ICER would be 76 Int.$/1% HbA1c reduction and 4812 Int$/QALY gained.</s><s xml:id="_h2tnMcc">The same effect on ICER would be observed if the effect on incremental accumulated QALYs was double (18 Int.$/1% HbA1c reduction and 1203 Int$/QALY gained) or half as big (76 Int.$/1% HbA1c reduction and 4812 Int$/QALY gained) as observed in the trial.</s><s xml:id="_PG2BChR">The benefits from increasing the program scope for a larger population would mean more cost-effective intervention at the population level.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_j2EERFK">Discussion</head><p xml:id="_SV2Ye9P"><s xml:id="_2Hgn2Dh">This randomized trial one of the first to present evidence on the cost-effectiveness of a text messaging intervention for type 2 diabetes in a LMIC.</s><s xml:id="_QmYEgJt">Results showed the intervention was an effective and potentially cost-effective strategy, highlighting the attractiveness of mHealth solutions for diabetes control.</s><s xml:id="_ZwuSuuR">Our results are similar to a study by Ramachandran and colleagues in southeast India reporting significant reductions in the incidence of type 2 diabetes in urban working men with impaired glucose tolerance who received text messages {Ramachandran, 2013 #421} <ref type="bibr" target="#b61">[62]</ref> .</s><s xml:id="_9TGt8An">The findings of our study differed to a recent study by Fottrell and colleagues <ref type="bibr" target="#b48">[49]</ref> , who showed no significant effect text messages on diabetes status.</s><s xml:id="_UxQBJEe">The differences in population demographics, randomization, and text messages contents, duration are different in these studies.</s><s xml:id="_VVvpnpm">The study showed a positive effect (albeit not statistically significant) on health-related quality of life and resulting accumulated QALYs over the observation period.</s><s xml:id="_evJyqbS">The calculation of the incremental costs showed that the text messaging intervention can be delivered at costs of 24 Int.$ per patient, resulting in ICERs of 38 Intl.$ per 1% reduction in HbA1c and 2406 Intl.$ per QALY gained.</s><s xml:id="_Vm4qmub">With this, the intervention is likely more cost-effective than similar mobile phone interventions in the US, where studies have reported 491$ <ref type="bibr" target="#b40">[41]</ref> and 29,869$ <ref type="bibr" target="#b41">[42]</ref> per 1% unit reduction in HbA1c, or 65,167$ per QALY gain <ref type="bibr" target="#b42">[43]</ref> .</s><s xml:id="_yxvpnfj">Compared with similar mHealth interventions for diabetes patients carried out in different settings, the intervention was comparable but less resource-intensive <ref type="bibr" target="#b17">[18]</ref> and more effective <ref type="bibr" target="#b49">[50]</ref> .</s><s xml:id="_EENYhQC">However, as intervention times, evaluation methods and settings, and the underlying population differ markedly between these studies, direct comparison is difficult.</s><s xml:id="_QXAce9b">Moreover, this evaluation is limited to the 6 months trial horizon and a sustained improvement of HbA1c is expected to lead to additional positive long-term health outcomes and cost savings.</s><s xml:id="_eHMWDp3">According to the updated UKPDS risk equations (UKPDS 82) a decrease in HbA1c by 1.5% would lead to a gain in life expectancy of 0.15 years in the UKPDS trial cohort <ref type="bibr" target="#b50">[51]</ref> .</s><s xml:id="_XqZZDVe">Noteworthy, this estimate neither fully captures the potential improvements in quality of life that occur from the prevention of non-fatal microand macro-vascular events nor the potential savings in health care spending associated with the prevention of those events.</s><s xml:id="_k6GagzV">However, the applicability of those equations to a Bangladeshi patient co-hort is uncertain and the expected gain in (quality-adjusted) life expectancy in our sample therefore unknown.</s><s xml:id="_mkKEBbJ">Therefore, long-term studies and evaluations are needed to improve the evidence base about the potential cost-effectiveness of such kind of interventions.</s></p><p xml:id="_SuRrftN"><s xml:id="_5MJwgQ8">No formal willingness-to-pay (WTP) threshold exists for Bangladesh.</s><s xml:id="_zWuJ3zK">However, according to guidelines from the WHO, one to three times a country's per capita gross domestic product could be used to represent the threshold for a highly costeffective intervention for averting a disability-adjusted life year (DALY) <ref type="bibr" target="#b39">[40]</ref> .</s><s xml:id="_zdZGbJF">Analysis of WTP for an additional QALY in industrialized countries showed that WTP thresholds averaged around twice the per capita gross national income.</s><s xml:id="_5U5xs86">Applying this concept to Bangladesh yields a WTP threshold of 7120 Intl.$ (year 2015) per QALY and indicates that the intervention is potentially highly cost-effective.</s></p><p xml:id="_AZF4Ma2"><s xml:id="_6ehjCkt">Given the simplicity of the text messaging intervention, there is considerable potential for upscaling and reaching a broader population of patients <ref type="bibr" target="#b51">[52]</ref> .</s><s xml:id="_rDmKzza">Moreover, a previous study demonstrated that participants with type 2 diabetes attending a tertiary hospital in Bangladesh were willing to pay a modest fee for receiving diabetes related SMS, which might help to develop a sustainable model for future clinical implications <ref type="bibr" target="#b52">[53]</ref> .</s><s xml:id="_Bd9g7BM">The intervention meets the major requirement of being technically simple; however, barriers such as the lack of experienced professionals for scaling the intervention and the often ineffective transmission of scientific evidence into a real world setting need to be overcome <ref type="bibr" target="#b53">[54]</ref> .</s><s xml:id="_uT3wGgm">Performing a basic budget impact analysis assuming linear scaling effects and costs and assuming that all people with type 2 diabetes in Bangladesh (7.1 million) receive the intervention yields costs of around 340 million Intl.$ and additional 14,200 QALYs annually.</s></p><p xml:id="_6pxeFZt"><s xml:id="_ESsjUmw">This study has two major limitations.</s><s xml:id="_WKnx6sc">The first is that we had no information on the use of healthcare resources over the follow-up period.</s><s xml:id="_HqsRXaR">One would assume that participants receiving reminders to take their medication and to visit their physician regularly would do so, resulting in an increase in healthcare utilization and costs.</s><s xml:id="_cW2N9sw">However, the severity of these limitations is hard to quantify.</s><s xml:id="_C22xvYk">Second, indirect costs related to hospitalization, healthcare facility use, household level costs and costs for medication, transport and blood tests were planned but were not available.</s><s xml:id="_HDYAGnw">Another major limitation is the short follow-up duration of the study and lack of data on those lost to follow up.</s><s xml:id="_twrusxj">It is questionable whether text messaging could alter habits such as inadequate medication adherence or health behavior within several months and show significant improvement in complex constructs such as quality of life.</s><s xml:id="_Pf8eH6B">Evidence about the long-term impact of mHealth interventions on quality of life, self-management, and health behavior is lacking <ref type="bibr">[ 33 , 55 ]</ref>.</s><s xml:id="_QG4nhSE">This also has major implications for the potential cost-effectiveness.</s><s xml:id="_eVBhT62">If the effects of an ongoing intervention are expected to dilute after a couple of months, the intervention will be less cost-effective in the long term.</s><s xml:id="_W5Y4gyK">In contrast, if the effects of an ongoing intervention are constant over time, then the intervention will be more cost-effective than suggested by the within-trial analyses, as upfront costs for design will be attributable over a longer time horizon.</s></p><p xml:id="_uSjcgDh"><s xml:id="_2cwxnMs">Another limitation is that the power of our study was sufficient to show significant changes in the primary outcome (HbA1c) but may be insufficient for secondary outcomes and quality of life.</s><s xml:id="_a3uwddd">Furthermore, as no EQ-5D value set is available for Bangladesh, QALY calculation was based on the preferences of the UK population and not on the preferences of the Bangladeshi population.</s><s xml:id="_TXwJGpn">Finally, the rather pragmatic extrapolation of the impact of the improvement in glycemic control on the 10-year CHD and stroke risk also has its limitations.</s><s xml:id="_xR3RqXM">First, the UKPDS engine is outdated, and the Asian Indians included in the UKPDS lived in the UK.</s><s xml:id="_zVrnZeF">Second, it is known that HbA1c has a larger effect on microvascular than on macrovascular complications, and therefore does underestimate the potential benefits to a patient's health.</s><s xml:id="_CzE3Bh4">As participation in the trial required living in a metropolitan city, ability to read mobile phone text messaging and taking oral medication, findings may not be generalised to Bangladeshi population and should be interpreted with caution.</s></p><p xml:id="_fSCebw6"><s xml:id="_49HWtAD">The findings of this study have implications for health policy and future research in Bangladesh.</s><s xml:id="_fdJnhqt">It is possible that large-scale implementation of the text messaging program would mean lower costs per patient improving communication, health behavior and access to equitable care <ref type="bibr" target="#b55">[56]</ref> and could be scaled us by the Government health programs <ref type="bibr" target="#b56">[57]</ref> .</s><s xml:id="_83WumEx">Evidence suggests that text messaging programs might are largely beneficial clinically and for the healthcare systems <ref type="bibr" target="#b57">[58]</ref> {Zurovac, 2012 #336} <ref type="bibr" target="#b62">[63]</ref> .</s><s xml:id="_kuqgmxU">Furthermore, a small change in HbA1c at an individual level might be a potential cost savings for the healthcare systems at a population level <ref type="bibr" target="#b58">[59]</ref> .</s><s xml:id="_NSAQHbA">A text messaging program would be more beneficial in lowresources settings including rural and remote areas where there is lack of trained healthcare professionals to improve diabetes knowledge and proving lifestyle advice for diabetes and other chronic diseases <ref type="bibr" target="#b59">[60]</ref> .</s><s xml:id="_Uuc9FpG">Text messages were sent at random and future research whether select messages tailored to participants particular stage of change and personalization would have a more substantial impact is warranted.</s><s xml:id="_MN2Q6Eh">In addition, future trials should consider the collection of detailed costing information including costs for text messaging platform, message delivery, human resources and training costs, maintenance and equipment costs.</s></p><p xml:id="_G4Bx7eT"><s xml:id="_gyFq2BM">In conclusion, a text messaging intervention in type 2 diabetes patients with oral medication in low-resource settings was costeffective in the short term.</s><s xml:id="_zJy6UpK">The findings of this study may have implications for large-scale public health initiatives for diabetes care in other LMICs and similar settings.</s><s xml:id="_EhDrDkc">Longer study followups including a detailed assessment of patient healthcare utilization are needed to further strengthen the evidence on the costeffectiveness of mHealth interventions for the treatment of type 2 diabetes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_tA4fsjb">CRediT authorship contribution statement</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p xml:id="_bA2fjcb"><s xml:id="_rCATS7M">Fig. 1.</s><s xml:id="_8mRjERX">CONSORT flow diagram.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc><div><p xml:id="_34GGTMZ"><s xml:id="_Z9E6SFv">Fig. 2. Theoretical foundation (logic) of the present report.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Clara K Chow :</head><label>Chow</label><figDesc><div><p xml:id="_MT6s5KW"><s xml:id="_uBT5cRb">Supervision, Writing -review &amp; editing.</s><s xml:id="_ev6fmq9">Ralph Maddison: Supervision, Writing -review &amp; editing.</s><s xml:id="_fX7UPy7">Andreas Lechner: Supervision, Writing -review &amp; editing.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p xml:id="_DJqfYz5"><s xml:id="_fmpejzz">Demographic and baseline characteristics of the study population.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell>Variable</cell><cell></cell><cell>Intervention</cell><cell>Control</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Mean (SD)</cell><cell>n</cell><cell>Mean (SD)</cell><cell>n</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Age</cell><cell></cell><cell>48.5 (9.2)</cell><cell>118</cell><cell>47.75 (10)</cell><cell>118</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Male n (%)</cell><cell></cell><cell>52 (44)</cell><cell>118</cell><cell>56 (47)</cell><cell>118</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Education (years)</cell><cell></cell><cell>9.1 (5.4)</cell><cell>118</cell><cell>9.3 (5.1)</cell><cell>118</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">Personal income (BDT)</cell><cell>13,379 (27,701)</cell><cell>118</cell><cell>17,003 (28,692)</cell><cell>118</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">Family income (BDT)</cell><cell>39,461 (34,159)</cell><cell>116</cell><cell>41,632 (40,043)</cell><cell>111</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">Years since DM diagnosis</cell><cell>2.3 (2.6)</cell><cell>118</cell><cell>2.3 (2.2)</cell><cell>118</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">Number of medications taken</cell><cell>3.5 (1.5)</cell><cell>116</cell><cell>3.6 (1.5)</cell><cell>118</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">Number of complications</cell><cell>1.7 (1.2)</cell><cell>118</cell><cell>1.7 (1.1)</cell><cell>118</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Less costs</cell></row><row><cell>Healthy lifestyle</cell><cell>Improved</cell><cell>Lower HbA1c</cell><cell>Fewer complications</cell><cell cols="2">Fewer medication + physician/clinic visits</cell></row><row><cell></cell><cell>Not</cell><cell>Higher</cell><cell>More</cell><cell cols="2">More medication +</cell></row><row><cell></cell><cell>improved</cell><cell>HbA1c</cell><cell>complications</cell><cell cols="2">physician/clinic visits</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>more costs</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p xml:id="_5S8qYxx"><s xml:id="_RjmBr5Y">Costs and effect measures and incremental cost-effectiveness ratios,.</s></p></div></figDesc><table><row><cell>Costs</cell><cell>Incremental costs intervention vs. control</cell></row><row><cell>Patient costs</cell><cell></cell></row><row><cell>SMS unit cost BDT (Intl.$)</cell><cell>1.1 (0.05)</cell></row><row><cell cols="2">Number of SMS sent °21,732</cell></row><row><cell>Total patient costs BDT (Intl.$)</cell><cell>23,905 (1031)</cell></row><row><cell>Program costs</cell><cell></cell></row><row><cell>Monthly salary</cell><cell>42,000 (1811)</cell></row><row><cell>Time spent by professional (months)</cell><cell>1</cell></row><row><cell>Total personnel costs BDT (Intl.$)</cell><cell>42,000 (1811)</cell></row><row><cell>Total intervention costs BDT (Intl.$)</cell><cell>65,905 (2842)</cell></row><row><cell>Mean costs per participant BDT (Intl.$)</cell><cell>558 (24)</cell></row><row><cell>Effects</cell><cell>Adjusted difference intervention vs. control</cell></row><row><cell>HbA1c change</cell><cell>-0.64 ( -0.95; 0.33)  *  *</cell></row><row><cell>Accumulated QALYs over 6 months</cell><cell>0.010 (0.000; 0.021)</cell></row><row><cell>Incremental cost-effectiveness ratios</cell><cell>BDT (Intl.$)</cell></row><row><cell>Costs/ HbA1c change</cell><cell>871 (38) per%HbA1c reduction</cell></row><row><cell>Costs/ QALY</cell><cell>55,800 (2406) per QALY gained</cell></row><row><cell cols="2">Adjusted for age, sex, and baseline values. Cost estimates were not adjusted as incremental</cell></row><row><cell cols="2">costs for the intervention only applied in the intervention group.</cell></row><row><cell cols="2">°21,600 to participants and 132 for testing purposes.</cell></row><row><cell>*  *  p &lt; 0.0 0 01; BDT Bangladesh Taka.</cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_v8G4V4d">Acknowledgments</head><p xml:id="_aP3tvMh"><s xml:id="_jznsY9f">We acknowledge the contribution of <rs type="person">Mr. Mathias Hunger</rs> of <rs type="affiliation">Helmholtz Zentrum Munich</rs> in designing the cost-effectiveness analysis.</s><s xml:id="_G9pWb2c">We would like to thank all the participants in this study and the management and staff of <rs type="institution">BIHS</rs> for their overall support.</s><s xml:id="_kJFjAZZ">This report was part of the Master's program of RP.</s></p></div>
			</div>
			<div type="funding">
<div><head xml:id="_bEsWwS6">Funding</head><p xml:id="_nb8nBX2"><s xml:id="_npWPg5k">This study received funding from the <rs type="funder">Center for International Health (CIH)</rs>, <rs type="funder">Ludwig-Maximilians-Universitat, Munich, Germany</rs>, and icddr,b (<rs type="grantNumber">GR#01</rs>,014).</s><s xml:id="_Kdsfu7e">We are grateful to <rs type="funder">ICDDR</rs>,B core donors and <rs type="funder">DAAD</rs>, <rs type="funder">BMZ</rs>, and <rs type="funder">EXCEED</rs> for supporting our study.</s><s xml:id="_VJuhkRg">SMSI is funded by a senior research fellowship from <rs type="funder">Institute for Physical Activity and Nutrition (IPAN)</rs>, <rs type="funder">Deakin University</rs> and received career transition grants from <rs type="funder">High Blood Pressure Research Council of Australia</rs>.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_w8ax4A8">
					<idno type="grant-number">GR#01</idno>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_qpBh33V"><p xml:id="_PUkrjx5"><s xml:id="_qKNGD9d">Data availability statement: Data for the study are available from First author upon reasonable request.</s></p><p xml:id="_sPDdrpX"><s xml:id="_zMyzfEe">Trial Registration: German Clinical Trial Registry No. DRKS0 0 0 05188.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QuJ8rx9">Author Statements</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EMRg9k4">Competing interests</head><p xml:id="_CTwePXt"><s xml:id="_5bwPVtf">None declared.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yTfM7ey">Ethical approval</head><p xml:id="_PbA5ywM"><s xml:id="_2m6bwuh">All patients provided written informed consent at enrollment.</s><s xml:id="_kRbcnub">The study protocol (PR#13,068) was approved by the Research Review Committee and Ethical Review Committee of the International Center for Diarrhoeal Diseases Research, Bangladesh (icccr,b) and received an Ethical Committee waiver from Ludwig-Maximilians-Universität (LMU) and BIHS.</s><s xml:id="_rRWeKYW">The study was conducted in accordance with the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Guideline for Good Clinical Practice and the Declaration of Helsinki 2008.</s><s xml:id="_eaz57S2">This trial was registered with the German Clinical Trial Registry (drks.de),</s><s xml:id="_S5SmDTb">DRKS0 0 0 05188.</s></p><p xml:id="_4mejZC8"><s xml:id="_m9VdyWB">Authors' contributions: SMSI, the principal investigator, was involved in the concept, design, and development of the intervention and the instruments, as well as in the reporting aspects of the report.</s><s xml:id="_fh8ZUQX">LN, ML, RH involved in the concept, design, selection of instruments and selection of the economic methods in the analyses, RP was responsible for the statistical analyses and the draft of this manuscript.</s><s xml:id="_y3Rg3s7">AL, CKC and RM provided substantial expert advice for the statistical analyses and reviewed the manuscript.</s><s xml:id="_yVx8bfK">All authors read and approved the final manuscript.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" xml:id="_xTBaVna">IDF diabetes atlas</title>
		<meeting><address><addrLine>Brussels, Belgium</addrLine></address></meeting>
		<imprint>
			<publisher>International Diabetes Federation</publisher>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Federation ID . IDF diabetes atlas. Brussels, Belgium: International Diabetes Federation; 2015 .</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_WmZuNUU">Diabetes in Asia and the Pacific: implications for the global epidemic</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nanditha</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc15-1536</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QKTv6EJ">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="472" to="485" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nanditha A , et al. Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes Care 2016;39(3):472-85 .</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_drAeT5w">Non-Communicable Diseases (NCDs) in developing countries: a symposium report</title>
		<author>
			<persName><forename type="first">Sms</forename><surname>Islam</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12992-014-0081-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DSUGUPR">Globalization Health</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">81</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Islam SMS , et al. Non-Communicable Diseases (NCDs) in developing countries: a symposium report. Globalization Health 2014;10(1):81 .</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_vBsyuqJ">Diabetes Estimates Bangladesh</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D F</forename></persName>
		</author>
		<ptr target="http://www.diabetesatlas.org/across-the-globe.html" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_tqPcmMq">IDF Diabetes Atlas</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>cited 2016 5.6.16 7th:Available from</note>
	<note type="raw_reference">I.D.F. Diabetes Estimates Bangladesh. IDF Diabetes Atlas 2015 [cited 2016 5.6.16]; 7th:Available from: http://www.diabetesatlas.org/across-the-globe. html .</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_6Dumdbv">Increasing prevalence of diabetes in Bangladesh: a scoping review</title>
		<author>
			<persName><forename type="first">T</forename><surname>Biswas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2PCs8re">Public Health</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="4" to="11" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Biswas T , et al. Increasing prevalence of diabetes in Bangladesh: a scoping re- view. Public Health 2016;138:4-11 .</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_Pf4fbpA">Clinical characteristics and complications of patients with type 2 diabetes attending an urban hospital in Bangladesh</title>
		<author>
			<persName><forename type="first">Sms</forename><surname>Islam</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.dsx.2014.09.014</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AQ7Y64h">Diabetes Metab Syndrome: Clin Res Rev</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="7" to="13" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Islam SMS , et al. Clinical characteristics and complications of patients with type 2 diabetes attending an urban hospital in Bangladesh. Diabetes Metab Syndrome: Clin Res Rev 2014;9(1):7-13 .</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_6Ewjk54">The impact of type 2 diabetes on health related quality of life in Bangladesh: results from a matched study comparing treated cases with non-diabetic controls</title>
		<author>
			<persName><forename type="first">N</forename><surname>Safita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Zu9MHpk">Health Qual Life Outcomes</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">129</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Safita N , et al. The impact of type 2 diabetes on health related quality of life in Bangladesh: results from a matched study comparing treated cases with non-diabetic controls. Health Qual Life Outcomes 2016;14(1):129 .</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_T8kMPtM">Risk factors for type 2 diabetes in Bangladesh: a systematic review</title>
		<author>
			<persName><forename type="first">Sal-Sabil T</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Shariful</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2vgc8Ye">J Diabetol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sal-sabil T , Islam A , Shariful Islam SM . Risk factors for type 2 diabetes in Bangladesh: a systematic review. J Diabetol 2016;2(4) .</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_5BWZM9V">Prevalence of depression and its associated factors in patients with type 2 diabetes: a cross-sectional study in Dhaka, Bangladesh</title>
		<author>
			<persName><forename type="first">Sms</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Rawal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Niessen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ajp.2015.07.008</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MCzjswk">Asian J Psychiatr</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="36" to="41" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Islam SMS , Rawal LB , Niessen LW . Prevalence of depression and its associ- ated factors in patients with type 2 diabetes: a cross-sectional study in Dhaka, Bangladesh. Asian J Psychiatr 2015;17:36-41 .</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_ARUwFyM">Association between depression and diabetes amongst adults in Bangladesh: a hospital based case-control study</title>
		<author>
			<persName><forename type="first">Sms</forename><surname>Islam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hHNF4Nn">J Global Health</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">20406</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Islam SMS , et al. Association between depression and diabetes amongst adults in Bangladesh: a hospital based case-control study. J Global Health 2015;5(2):020406 .</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_PyKjDv9">Healthcare use and expenditure for diabetes in Bangladesh</title>
		<author>
			<persName><forename type="first">Shariful</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hW7ssd3">BMJ Global Health</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shariful Islam SM , et al. Healthcare use and expenditure for diabetes in Bangladesh. BMJ Global Health 2017;2(1) .</note>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main" xml:id="_Et4AWrq">Basic statistics, Asia and the Pacific</title>
		<idno type="DOI">10.22617/arm240241-2</idno>
		<imprint>
			<date type="published" when="2019">2019</date>
			<publisher>ERCD</publisher>
			<pubPlace>Manila, Philippines</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Asian Development Bank</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Asian Development Bank. Basic statistics, Asia and the Pacific. Manila, Philip- pines: Asian Development Bank, ERCD; 2019 .</note>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title level="m" type="main" xml:id="_DKcHEh5">Universal access: how mobile can bring communications to all</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Gsma</surname></persName>
		</author>
		<idno type="DOI">10.1201/9781420064995-59</idno>
		<ptr target="http://www.gsmworld.com/documents/universal_access_full_report.pdf" />
		<imprint>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>cited 2016 2.3.16</note>
	<note type="raw_reference">GSMA , G.A .. Universal access: how mobile can bring communications to all; 2008. [cited 2016 2.3.16]Available from: http://www.gsmworld.com/ documents/universal _ access _ full _ report.pdf .</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_P4S2aaJ">Mobile phone intervention for increasing adherence to treatment for type 2 diabetes in an urban area of Bangladesh: protocol for a randomized controlled trial</title>
		<author>
			<persName><forename type="first">Sms</forename><surname>Islam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BZ7AQfu">BMC Health Services Res</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">586</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Islam SMS , et al. Mobile phone intervention for increasing adherence to treat- ment for type 2 diabetes in an urban area of Bangladesh: protocol for a ran- domized controlled trial. BMC Health Services Res 2014;14(1):586 .</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_hYW3kkP">Text messaging as a tool for behavior change in disease prevention and management</title>
		<author>
			<persName><forename type="first">H</forename><surname>Cole-Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kershaw</surname></persName>
		</author>
		<idno type="DOI">10.1093/epirev/mxq004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SnDR3rJ">Epidemiol Rev</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="56" to="69" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cole-Lewis H , Kershaw T . Text messaging as a tool for behavior change in dis- ease prevention and management. Epidemiol Rev 2010;32(1):56-69 .</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_xCvQ8PH">SMS for disease control in developing countries: a systematic review of mobile health applications</title>
		<author>
			<persName><forename type="first">C</forename><surname>Deglise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Suggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Odermatt</surname></persName>
		</author>
		<idno type="DOI">10.1258/jtt.2012.110810</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YkBjhb6">J Telemed Telecare</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="273" to="281" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Deglise C , Suggs LS , Odermatt P . SMS for disease control in developing coun- tries: a systematic review of mobile health applications. J Telemed Telecare 2012;18(5):273-81 .</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_4UjVaEB">mHealth SMS text messaging interventions and to promote medication adherence: an integrative review</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dekoekkoek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WbMHByC">J Clin Nurs</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">19-20</biblScope>
			<biblScope unit="page" from="2722" to="2735" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">DeKoekkoek T , et al. mHealth SMS text messaging interventions and to promote medication adherence: an integrative review. J Clin Nurs 2015;24(19-20):2722-35 .</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_YD2BVej">A nurse short message service by cellular phone in type-2 diabetic patients for six months</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Jeong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_y4Wygj2">J Clin Nurs</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1082" to="1087" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kim HS , Jeong HS . A nurse short message service by cellular phone in type-2 diabetic patients for six months. J Clin Nurs 2007;16(6):1082-7 .</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_4TbNNrX">Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dobson</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.k1959</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YcCQuWa">BMJ</title>
		<imprint>
			<biblScope unit="page">361</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dobson R , et al. Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial. BMJ 2018:361 .</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_bjeqDvR">Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2015.10945</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6DQUzTs">JAMA</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1255" to="1263" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK , et al. Effect of lifestyle-focused text messaging on risk factor mod- ification in patients with coronary heart disease: a randomized clinical trial. JAMA 2015;314(12):1255-63 .</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_zuQ6V52">Mobile phone text messages to support treatment adherence in adults with high blood pressure (SMS-Text Adherence Support [StAR])</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bobrow</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.115.017530</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pzrfFFb">Circulation</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="592" to="600" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bobrow K , et al. Mobile phone text messages to support treatment adherence in adults with high blood pressure (SMS-Text Adherence Support [StAR]). Cir- culation 2016;133(6):592-600 .</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_ZYpggzn">Mobile phone-based interventions for smoking cessation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Whittaker</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd006611.pub4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5Zy3vWt">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">6611</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Whittaker R , et al. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev 2016;4:Cd006611 .</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_pYSMBkg">Text2PreventCVD: protocol for a systematic review and individual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseases</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xkcAVkf">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">12723</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK , et al. Text2PreventCVD: protocol for a systematic review and indi- vidual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseases. BMJ Open 2016;6(10):e012723 .</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_MDwcMQH">Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial</title>
		<author>
			<persName><forename type="first">Shariful</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3YpA9UW">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">22637</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shariful Islam SM , et al. Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME ran- domised controlled trial. BMJ Open 2019;9(2):e022637 .</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_5ZK2Dvm">Effects of mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: a prospective, parallel-group, randomized controlled trial</title>
		<author>
			<persName><forename type="first">Shariful</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hfMgryN">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="112" to="e113" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shariful Islam SM , et al. Effects of mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: a prospec- tive, parallel-group, randomized controlled trial. Diabetes Care 2015;38(8): e112-e113 .</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_e5xQ9fQ">What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Iribarren</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0170581</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TAjvwJK">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">170581</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Iribarren SJ , et al. What is the economic evidence for mHealth? A sys- tematic review of economic evaluations of mHealth solutions. PLoS ONE 2017;12(2):e0170581 .</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_2zYgbTK">The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop</title>
		<author>
			<persName><forename type="first">C</forename><surname>Guerriero</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10198-012-0424-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RqHEPjN">Eur J Health Econ</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="789" to="797" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guerriero C , et al. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. Eur J Health Econ 2013;14(5):789-97 .</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_t9fm4Er">Text and mobile media smoking cessation service for young adults in South Texas: operation and cost-effectiveness estimation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Ramirez</surname></persName>
		</author>
		<idno type="DOI">10.1177/1524839917705130</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JeAj9rY">Health Promotion Pract</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="581" to="585" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ramirez AG , et al. Text and mobile media smoking cessation service for young adults in South Texas: operation and cost-effectiveness estimation. Health Pro- motion Pract 2017;18(4):581-5 .</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_nRSP8aV">Cost-effectiveness of telehealth for patients with depression: evidence from the Healthlines randomised controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dixon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CY3ZtAx">BJPsych Open</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="262" to="269" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dixon P , et al. Cost-effectiveness of telehealth for patients with depres- sion: evidence from the Healthlines randomised controlled trial. BJPsych Open 2016;2(4):262-9 .</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_GfBuwW7">Evaluation of the National Health Service (NHS) direct pilot telehealth program: cost-effectiveness analysis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Malcolm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ESdHsHq">Telemed e-Health</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="67" to="76" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Malcolm C , et al. Evaluation of the National Health Service (NHS) di- rect pilot telehealth program: cost-effectiveness analysis. Telemed e-Health 2018;24(1):67-76 .</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_C6xdgRD">Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dixon</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2016-012352</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cNvRXrE">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">12352</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dixon P , et al. Cost-effectiveness of telehealth for patients with raised car- diovascular disease risk: evidence from the Healthlines randomised controlled trial. BMJ Open 2016;6(8):e012352 .</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_g9jUW4F">Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events</title>
		<author>
			<persName><forename type="first">E</forename><surname>Burn</surname></persName>
		</author>
		<idno type="DOI">10.1136/heartjnl-2016-310195</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_P3YVwq8">Heart</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="893" to="894" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Burn E , et al. Cost-effectiveness of a text message programme for the preven- tion of recurrent cardiovascular events. Heart 2017;103(12):893-4 .</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_85gqB6h">Clinical-and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Zhai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TETNQT7">Medicine</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">28</biblScope>
			<biblScope unit="page">e312</biblScope>
			<date type="published" when="2014">2014</date>
			<pubPlace>Baltimore</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhai YK , et al. Clinical-and cost-effectiveness of telemedicine in type 2 dia- betes mellitus: a systematic review and meta-analysis. Medicine (Baltimore) 2014;93(28):e312 .</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_hqNW6sw">Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus</title>
		<author>
			<persName><forename type="first">K</forename><surname>Pal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PcubsRY">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">3</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pal K , et al. Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev 2013(3) .</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_nR5z8Gs">Guidelines for care of type 2 diabetes mellitus in Bangladesh</title>
		<author>
			<persName><forename type="first">H</forename><surname>Mahtab</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RkNQ9r9">BIRDEM Clinical Res Gr</title>
		<imprint>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mahtab, H., et al., Guidelines for care of type 2 diabetes mellitus in Bangladesh. BIRDEM Clinical Res Gr, 2003.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_Su67m5R">Standards of medical care in diabetes -2013</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Association</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc13-s011</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Em2PSxD">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">Suppl 1</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Association AD . Standards of medical care in diabetes -2013. Diabetes Care 2013;36(Suppl 1):S11 .</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_SaXUxJU">Transtheoretical model-based multiple behavior intervention for weight management: effectiveness on a population basis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FqQ2DrJ">Prev Med</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="238" to="246" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Johnson SS , et al. Transtheoretical model-based multiple behavior interven- tion for weight management: effectiveness on a population basis. Prev Med 2008;46(3):238-46 .</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_uuqWXSN">Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Davies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DzWbcsH">BMJ</title>
		<imprint>
			<biblScope unit="volume">336</biblScope>
			<biblScope unit="issue">7642</biblScope>
			<biblScope unit="page" from="491" to="495" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Davies MJ , et al. Effectiveness of the diabetes education and self manage- ment for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ 2008;336(7642):491-5 .</note>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<author>
			<orgName type="collaboration">WHO</orgName>
		</author>
		<idno type="DOI">10.1186/1478-7547-1-8</idno>
		<title level="m" xml:id="_Pdsagqs">Cost effectiveness and strategic planning</title>
		<imprint>
			<publisher>WHO-CHOICE</publisher>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">WHO. Cost effectiveness and strategic planning (WHO-CHOICE); 2014 .</note>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title level="m" type="main" xml:id="_XtMbW5P">WHO Making choices in health: WHO guide to cost-effectiveness analysis Making choices in health: WHO guide to cost-effectiveness analysis</title>
		<editor>Edejer TT-T, et al.</editor>
		<imprint>
			<date type="published" when="2003">2003</date>
			<publisher>Editors</publisher>
			<pubPlace>Geneva, Switzerland</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">WHO Making choices in health: WHO guide to cost-effectiveness analysis Mak- ing choices in health: WHO guide to cost-effectiveness analysis. Edejer TT-T, et al., editors. Geneva, Switzerland: Editors; 2003 .</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_xFQRzff">Intervention costs and cost-effectiveness of a successful telephonic intervention to promote diabetes control</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Schechter</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc12-0048</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6N5FRzf">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2156" to="2160" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schechter CB , et al. Intervention costs and cost-effectiveness of a suc- cessful telephonic intervention to promote diabetes control. Diabetes Care 2012;35(11):2156-60 .</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_sQpZkHY">Costs to Medicare of the Informatics for Diabetes Education and Telemedicine (IDEATel) home telemedicine demonstration: findings from an independent evaluation</title>
		<author>
			<persName><forename type="first">L</forename><surname>Moreno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ghmz3Fs">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1202" to="1204" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moreno L , et al. Costs to Medicare of the Informatics for Diabetes Education and Telemedicine (IDEATel) home telemedicine demonstration: findings from an independent evaluation. Diabetes Care 2009;32(7):1202-4 .</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_NyMSSkP">Cost-effectiveness of automated telephone self-management support with nurse care management among patients with diabetes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Handley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shumway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schillinger</surname></persName>
		</author>
		<idno type="DOI">10.1370/afm.889</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JnuscSb">Ann Fam Med</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="512" to="518" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Handley MA , Shumway M , Schillinger D . Cost-effectiveness of automated tele- phone self-management support with nurse care management among patients with diabetes. Ann Fam Med 2008;6(6):512-18 .</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_rJX58mw">From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rabin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RsMVHxn">Value Health</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="70" to="76" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rabin R , et al. From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional ques- tionnaire. Value Health 2014;17(1):70-6 .</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_PKMD7Ye">The time trade-off method: results from a general population study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dolan</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1099-1050(199603)5:2&lt;141::aid-hec189&gt;3.0.co;2-n</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wNa75En">Health Econ</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="141" to="154" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dolan P , et al. The time trade-off method: results from a general population study. Health Econ 1996;5(2):141-54 .</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_jffu95b">QALYs: the basics</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Weinstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Torrance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mcguire</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CB8NDJN">Value Health</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="5" to="9" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Weinstein MC , Torrance G , McGuire A . QALYs: the basics.. Value Health 2010;12:S5-9 .</note>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title level="m" type="main" xml:id="_2ndcxbP">XE Währungsdiagramme (USD/BDT)</title>
		<author>
			<persName><surname>Xe</surname></persName>
		</author>
		<ptr target="http://www.xe.com/currencycharts/?from=USD&amp;to=BDT&amp;view=2Y" />
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>cited 2016 03.07.2016</note>
	<note type="raw_reference">XE. XE Währungsdiagramme (USD/BDT); 2016. [cited 2016 03.07.2016]; Avail- able from: http://www.xe.com/currencycharts/?from=USD&amp;to=BDT&amp;view=2Y .</note>
</biblStruct>

<biblStruct xml:id="b47">
	<monogr>
		<title level="m" type="main" xml:id="_XdKZPfj">PPP conversion factor -International Comparison Program database</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Bank</surname></persName>
		</author>
		<ptr target="http://data.worldbank.org/indicator/PA.NUS.PPP" />
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>cited 2016 01.01.2016</note>
	<note type="raw_reference">Bank TW. PPP conversion factor -International Comparison Program database; 2016. [cited 2016 01.01.2016]; Available from: http://data.worldbank.org/ indicator/PA.NUS.PPP .</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_UCbUrVY">Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trial</title>
		<author>
			<persName><forename type="first">E</forename><surname>Fottrell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5gznSKu">Lancet Diabetes Endocrinol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="200" to="212" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fottrell E , et al. Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trial. Lancet Diabetes Endocrinol 2019;7(3):200-12 .</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_dRNVbuQ">Evaluation of a remote monitoring system for diabetes control</title>
		<author>
			<persName><forename type="first">B</forename><surname>Katalenich</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.clinthera.2015.03.022</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JfMX8H7">Clin Ther</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1216" to="1225" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Katalenich B , et al. Evaluation of a remote monitoring system for diabetes con- trol. Clin Ther 2015;37(6):1216-25 .</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_K3ezBHv">UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Hayes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AAzcyNu">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1925" to="1933" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hayes AJ , et al. UKPDS Outcomes Model 2: a new version of a model to sim- ulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia 2013;56(9):1925-33 .</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_2nkaQUT">mHealth in cardiovascular health care</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jB8E2ya">Heart Lung Circ</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="802" to="807" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK , et al. mHealth in cardiovascular health care. Heart Lung Circ 2016;25(8):802-7 .</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_99kgecc">Mobile phone use and willingness to pay for SMS for diabetes in Bangladesh</title>
		<author>
			<persName><forename type="first">Sms</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Ferrari</surname></persName>
		</author>
		<author>
			<persName><surname>La</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Seissler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Holle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Niessen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_umwYSJB">J Public Health</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="163" to="169" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Islam SMS , Ferrari U LA , Seissler J , Holle R , Niessen LW . Mobile phone use and willingness to pay for SMS for diabetes in Bangladesh. J Public Health 2016;38(1):163-9 .</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_6ekCdaz">What are the barriers to scaling up health interventions in low and middle income countries? A qualitative study of academic leaders in implementation science</title>
		<author>
			<persName><forename type="first">G</forename><surname>Yamey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FSAdZhp">Globalization Health</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yamey G . What are the barriers to scaling up health interventions in low and middle income countries? A qualitative study of academic leaders in imple- mentation science. Globalization Health 2012;8:11 .</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_jsgHKmu">Mobile phone and smartphone technologies for diabetes care and self-management</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Garabedian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ross-Degnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Wharam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8s8GgrN">Curr Diab Rep</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">109</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Garabedian LF , Ross-Degnan D , Wharam JF . Mobile phone and smart- phone technologies for diabetes care and self-management. Curr Diab Rep 2015;15(12):109 .</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_tfPTFZK">Policy statement: texting in health care</title>
		<author>
			<persName><forename type="first">L</forename><surname>Storck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pHfAdsG">On-Line J Nurs Inf</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storck L . Policy statement: texting in health care. On-Line J Nurs Inf 2017;21(1) .</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_CPJRCAT">Implementation of information and communication technologies for health in Bangladesh</title>
		<author>
			<persName><forename type="first">Sms</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tabassum</surname></persName>
		</author>
		<idno type="DOI">10.2471/blt.15.153684</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_p9s2Rjy">Bull World Health Org</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="806" to="809" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Islam SMS , Tabassum R . Implementation of information and communi- cation technologies for health in Bangladesh. Bull World Health Org 2015;93(11):806-9 .</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_FmcjxZE">Text messaging in health care: a systematic review of impact studies</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Yeager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Menachemi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gR5Mmzu">Adv Health Care Manag</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="235" to="261" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yeager VA , Menachemi N . Text messaging in health care: a systematic review of impact studies. Adv Health Care Manag 2011;11:235-61 .</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_y8XEBhE">Mobile phone text-messaging interventions aimed to prevent cardiovascular diseases (Text2PreventCVD): systematic review and individual patient data meta-analysis</title>
		<author>
			<persName><forename type="first">Sms</forename><surname>Islam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sFcVcEV">Open Heart</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e001017</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Islam SMS , et al. Mobile phone text-messaging interventions aimed to prevent cardiovascular diseases (Text2PreventCVD): systematic review and individual patient data meta-analysis. Open Heart 2019;6(2):e001017 .</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_8ZZnUBc">Diabetes knowledge and glycemic control among patients with type 2 diabetes in Bangladesh</title>
		<author>
			<persName><forename type="first">Shariful</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_V9BQHCN">Springerplus</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">284</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shariful Islam S , et al. Diabetes knowledge and glycemic control among pa- tients with type 2 diabetes in Bangladesh. Springerplus 2015;4(284) .</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_6YUAuPc">Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Knapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kalra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DgMvRqN">Stroke</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="196" to="203" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patel A , Knapp M , Perez I , Evans A , Kalra L . Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective random- ized controlled trial. Stroke 2004;35:196-203 .</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_4aUjVjH">Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ramachandran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Snehalatha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ram</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5bBqMRS">The lancet Diabetes &amp; endocrinology</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="191" to="198" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ramachandran A , Snehalatha C , Ram J , et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. The lancet Diabetes &amp; endocrinology 2013;1:191-8 .</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_pWPQRep">Costs and cost-effectiveness of a mobile phone text-message reminder programmes to improve health workers&apos; adherence to malaria guidelines in Kenya</title>
		<author>
			<persName><forename type="first">D</forename><surname>Zurovac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Sudoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Snow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RFnmuQN">PloS one</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e52045</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zurovac D , Larson BA , Sudoi RK , Snow RW . Costs and cost-effectiveness of a mobile phone text-message reminder programmes to improve health workers&apos; adherence to malaria guidelines in Kenya. PloS one. 2012;7:e52045 .</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
